| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Link Popularity > Link Exchanges - Good or Bad? |
|
Just Other Articles - Link Exchanges - Good or Bad?
All too often a hot thread will pop up in a forum where another worried, confused, trying-to-do-it-right webmaster is asking According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product the "experts" about Google's policy regarding link exchanges. Every time the question of linking comes up, a line is drawn in ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in the sand, and the two sides go at it. Here are a couple of typical responses: "I still think getting links is lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. a good idea. There are some topics on the web that that's all visitors do is follow links." "Link exchanges will end up kill here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ing a site, many people who have them find themselves under a penalty now." Very seldom will anyone from either d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro side of the link exchange issue offer definite proof of their argument. Each post is colored with slight variations on the de ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc gree to which it is bad or good. Each poster tries desperately to establish some credibility for themselves while arguing tha easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t their actions and decisions are the RIGHT way and this leads quickly to another heated, circular debate with no clear winne nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rs. This leaves the person asking the original question more confused than they were when they asked it in the first place. and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ Frankly, no one has any idea what Google, or any other search engine, will like or not like. What worked before may not work ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ow, and no one can give a definitive answer as to why. As the old Zen master once said, "It is what it is." Now logic dictat ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a es that Google does not want to penalize sites engaging in link exchanges. What Google wants is to please the people that rel dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod y on them to provide a quality resource. How does exchanging links or the avoidance of the practice, define a quality resour cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ce? It doesn't. People define a quality resource, and therein lies the answer to what approach one should take regarding exch tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen anging links. As a person you are completely competent to know when exchanging a link increases or decreases the quality of t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel our web site. If anything you do, including linking to a web site that links to you, increases the quality, that is good. If ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the exchanging of links decreases the quality, that is bad. Remember this: You have every right to do whatever you think is y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products best for your web site. You can't control Google, but you can control your site. If you exchange links or do not exchange li . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nks because you think it will make Google do something, your chances of losing at some point go way up. If you exchange links elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip or don't exchange links because it makes your site better, then you win. And doesn't it make sense that Google wants winners tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Internet's Top Ten: Why They Work Who Loves Money - An Honest Review
|